CN104622998A - Applications of fructus sorbus sibirica extract in preparation of lipid-lowering medicament - Google Patents

Applications of fructus sorbus sibirica extract in preparation of lipid-lowering medicament Download PDF

Info

Publication number
CN104622998A
CN104622998A CN201510009893.0A CN201510009893A CN104622998A CN 104622998 A CN104622998 A CN 104622998A CN 201510009893 A CN201510009893 A CN 201510009893A CN 104622998 A CN104622998 A CN 104622998A
Authority
CN
China
Prior art keywords
sorbus sibirica
sorbus
fruit extract
fructus
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510009893.0A
Other languages
Chinese (zh)
Inventor
魏杰
高军
范俊岗
周志权
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning University
Original Assignee
Liaoning University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liaoning University filed Critical Liaoning University
Priority to CN201510009893.0A priority Critical patent/CN104622998A/en
Publication of CN104622998A publication Critical patent/CN104622998A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to applications of fructus sorbus sibirica extract in preparation of a lipid-lowering medicament. The fructus sorbus sibirica extract can be used alone or combined with other lipid-lowering medicaments, to prepare medicaments or healthy products of any dosage form suitable for oral administration. The fructus sorbus sibirica extract has strong lipid-lowering capacity.

Description

The application of Sorbus sibirica fruit extract in preparation treatment fat-reducing medicament
Technical field
The invention belongs to the purposes field of medicine, relate to Sorbus sibirica fruit extract particularly and preparing the application in the medicine or health product with effect for reducing fat.
Background technology
The content of one or more lipids that hyperlipidemia refers in blood exceedes disease during normal high limit, also can be described as hyperlipoproteinemia, epidemiologic data shows, be 18.6% in the prevalence of Chinese adult dyslipidemia, that is, the number of patients with dyslipidemia reaches 100,000,000 6 thousand ten thousand, also it was reported that the whole world every year nearly 1,200 ten thousand people die from cardiovascular diseases and apoplexy, hyperlipemia is the pathological changes basis of AS, main manifestations is plasma TC and (or) TG, and (or) HDL-C level is too low, therefore prevention and therapy hyperlipemia receives the extensive attention of medical circle.
And existing Therapeutic Method mostly adopts the medicine of chemosynthesis, its cost is large, and toxicity is large, and side effect is strong, and such as statins has similar myalgia, affects coenzyme Q10 synthesis, affects the side effect such as health of heart further.Therefore, find from natural plants and there is material that is bioactive, antilipemic effect be applied in medicine, food and health product and have great importance.
Sorbus sibirica is Rosaceae (Rosaceae) Fructus Sorbi Pohuashanensis, belongs to dungarunga, is only distributed in upstream, Burqin river in China, under liking being grown on PiceameyeriRehd. Et Wils. and fir mixed forest, its tree-like grace, figure hold directly, and leaf is large-scale winglike compound leaf, is rich in ornamental value.Spring, snow-white flower completely set fragrance, and the scarlet wish of mellow fruit in autumn is dripped.It is edible that fruit is rich in multivitamin, has ascorbic acid (200mg/100g), and carotene (18mg/100g), VP, Sorbitol, organic acid, VC etc., its fresh fruit Polyphenols content reaches 25% ~ 35%.
Summary of the invention
The present invention is for the purpose of the exploitation for seeking new and effective blood fat reducing medicine or health product, proposes the application of Sorbus sibirica fruit extract in the medicine preparing effect for reducing blood fat or health product.
The present invention adopts Sorbus sibirica fruit extract as raw material, alone or with other, there is the drug regimen of effect for reducing blood fat, the preparation method of preparation routinely, be prepared into the medicine with effect for reducing blood fat or the health product of applicable oral any dosage form, as oral liquid, tablet, capsule, granule etc.; Or other injection dosage form.
What the present invention adopted is Sorbus sibirica fruit alcohol extraction extract, drawn by hyperlipemia model mice experiment in vivo, Sorbus sibirica fruit extract can reduce cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), HDL-C (HDL-C) content in hyperlipemia in mice serum, and liver is heavy.Therefore, Sorbus sibirica fruit extract has effect of blood fat reducing regulating liver-QI fat, is a good selection of the efficient natural fat-reducing medicament of development of new or health product.
Detailed description of the invention
The application of embodiment 1 Sorbus sibirica fruit extract in preparation treatment fat-reducing medicament
(1) preparation method
The preparation of Sorbus sibirica fruit extract: take Sorbus sibirica fruit 100g, ethanol with 60% soaks 1h at 60-70 DEG C, put into the ultrasonic 30min of ultrasonic cleaner, continuous 2 times, use Rotary Evaporators concentrated extracting solution again, obtain Sorbus sibirica fruit extract dry powder through vacuum lyophilization.
(2) test of pesticide effectiveness
Animal feeding and process: within 1 week, to adapt to this laboratory condition, sub-cage rearing, indoor Aseptic sterilisation, changes bedding and padding in every two days to experimental animal feeding.Bright-the 12h of Control release room illumination 12h is dark, and indoor temperature is 20 ± 1 DEG C, and humidity is 55 ± 10%.
Laboratory animal divide into groups: male mice 60, body weight 30 ± 2g, be divided at random 5 groups as follows, often group 10.
(1) Normal group (Normal group, N);
(2) hyperlipidemia model group (High-lipid diet model group, H);
(3) Fructus Sorbi Pohuashanensis fruit extract low dose group (polyphenol lower dose group, PL) (0.3mg/d);
(4) dosage group (polyphenol middle dose group, PM) (1.5mg/d) in Fructus Sorbi Pohuashanensis fruit extract;
(5) Fructus Sorbi Pohuashanensis fruit extract high dose group (polyphenol higher dose group, PH) (3mg/d);
After conforming one week, except normal control, other is respectively organized mice and all changes and feed high lipid food (10% Adeps Sus domestica, 1% cholesterol, 15% sucrose) and bring out hyperlipemia, often organizes ad lib and drinking-water, Fructus Sorbi Pohuashanensis fruit extract doses group gastric infusion.In test, a body weight was claimed to change single administration dosage every 7 days.When experiment the 21st day, fasting 12h (can't help water), extract eyeball and get blood, dislocation is put to death, get liver, detect TC, TG, LDL-C, HDL-C level content in blood and liver homogenate, according to TC, TG, LDL-C, HDL-C index in serum in Shenyang Ding Guo Bioisystech Co., Ltd test kit description method mensuration Mice Body.Result is as table 1.
The impact that table 1 Sorbus sibirica fruit polyphenol weighs lipid of mice level and liver
As can be seen from Table 1, compared with normal group mice, TC, TG, LDL-C level content in model group mice serum and liver weight average are significantly higher than Normal group (P<0.05), HDL-C is significantly lower than matched group (P<0.05), show to feed high lipid food by this test method to mice, can successfully set up hyperlipidemia mouse model.
Compare with hyperlipidemia model group, the basic, normal, high dosage group of Sorbus sibirica fruit extract, can significantly reduce TC, TG, LDL-C, HDL-C level content, and liver is heavy and body weight.Fructus Sorbi Pohuashanensis fruit extract using dosage is not high simultaneously, and Be very effective is described.
Result shows that Sorbus sibirica fruit extract has the effect obviously reducing TC, TG, LDL-C, HDL-C content, reduces liver and weighs and body weight, illustrate that it has effect of blood fat reducing regulating liver-QI fat.Conclusion: the ability of Sorbus sibirica fruit extract blood fat reducing is strong is a good selection of the efficient natural fat-reducing medicament of development of new or health product.

Claims (4)

1. Sorbus sibirica fruit extract is alone or preparing the application for the treatment of in fat-reducing medicament with other drug regimens with effect for reducing fat.
2. apply as claimed in claim 1, it is characterized in that: described Sorbus sibirica fruit extract is alcohol extraction compound.
3. apply as claimed in claim 1 or 2, it is characterized in that: the preparation of described Sorbus sibirica fruit extract: take Sorbus sibirica fruit 100g, ethanol with 60% soaks 1h at 60-70 DEG C, put into the ultrasonic 30min of ultrasonic cleaner, continuous 2 times, use Rotary Evaporators concentrated extracting solution again, obtain Sorbus sibirica fruit extract dry powder through vacuum lyophilization.
4. apply as claimed in claim 1 or 2, it is characterized in that: the dosage of described Sorbus sibirica fruit extract is 0.3-3mg/d.
CN201510009893.0A 2015-01-05 2015-01-05 Applications of fructus sorbus sibirica extract in preparation of lipid-lowering medicament Pending CN104622998A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510009893.0A CN104622998A (en) 2015-01-05 2015-01-05 Applications of fructus sorbus sibirica extract in preparation of lipid-lowering medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510009893.0A CN104622998A (en) 2015-01-05 2015-01-05 Applications of fructus sorbus sibirica extract in preparation of lipid-lowering medicament

Publications (1)

Publication Number Publication Date
CN104622998A true CN104622998A (en) 2015-05-20

Family

ID=53202560

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510009893.0A Pending CN104622998A (en) 2015-01-05 2015-01-05 Applications of fructus sorbus sibirica extract in preparation of lipid-lowering medicament

Country Status (1)

Country Link
CN (1) CN104622998A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106177015A (en) * 2016-08-01 2016-12-07 吉林大学 Sorbus domestica application in preparing xanthine oxidase inhibitor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101481643A (en) * 2008-12-25 2009-07-15 辽宁省干旱地区造林研究所 Aroniamelanocarpa fruit wine and brewing method thereof
CN103211881A (en) * 2013-04-12 2013-07-24 辽宁大学 Application of sorbus sibirica fruit in preparation of drug or health-care product with anti-oxidation effect

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101481643A (en) * 2008-12-25 2009-07-15 辽宁省干旱地区造林研究所 Aroniamelanocarpa fruit wine and brewing method thereof
CN103211881A (en) * 2013-04-12 2013-07-24 辽宁大学 Application of sorbus sibirica fruit in preparation of drug or health-care product with anti-oxidation effect

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
关明等: "新疆天山花楸叶中总黄酮的提取及其含量测定", 《生命科学仪器》 *
赵永昕等: "新疆两种花楸不同部位总黄酮的提取及其含量比较", 《天然产物研究与开发》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106177015A (en) * 2016-08-01 2016-12-07 吉林大学 Sorbus domestica application in preparing xanthine oxidase inhibitor

Similar Documents

Publication Publication Date Title
CN101836691B (en) Chinese medicinal herb feed additive
CN101953985A (en) Drug with function of removing heat from lung to relieve cough
CN102885184A (en) Shallot-ginger cold-dispelling tea and preparation method thereof
CN102091314B (en) Composition of dried ginger and evodia rutaecarpa, preparation method thereof and application thereof in preparing attenuating synergistic medicament in radiotherapy and chemotherapy of cancer
CN104739840A (en) Novel use of asiatic acid in preparation of drugs for preventing and treating hyperlipidemia and fatty liver
CN104622998A (en) Applications of fructus sorbus sibirica extract in preparation of lipid-lowering medicament
CN102631466A (en) Health care product for regulating blood lipid and preparation method thereof
CN105106300A (en) Use of cyclocarya paliurus extract in preparation of drug for preventing and treating non-alcoholic fatty liver disease
CN102091313B (en) Composition of perilla leaf and ginger, preparation method thereof and application thereof in preparing attenuating synergistic medicament in radiotherapy and chemotherapy of cancer
CN106138164A (en) A kind of compound Chinese medicinal preparation with Adjust-blood lipid function
CN107890486A (en) A kind of Chinese medicine external anti-inflammation formulation and its preparation method and application
CN101721437B (en) Preparation method of medicine composition used for treating chronic pharyngitis
CN105902561A (en) Application of Gracilariopsis lemaneiformis polysaccharide as antitumor chemotherapy drug synergist and antitumor drug
CN101502536B (en) Cedar total flavone as well as preparation method and medical use
CN101822701B (en) Poplar flower sustained release tablet for treating livestock and poultry dysentery and enteritis and preparation method thereof
CN101912439B (en) Technology for extracting Chinese angelica and lightyellow sophora root
CN104069149A (en) Method for processing traditional Chinese medicine decoction piece by using bear gall as matrix
CN104013717B (en) A kind of soft capsule of anti-Sendai virus pulmonary infection
CN103263475A (en) Traditional chinese medicine composition
CN102836198A (en) Cancer-restraining medicine and preparation method thereof
CN103006749A (en) New application of luffa seed
CN104208168B (en) A kind of for compound traditional Chinese medicine composite treating poultry respiratory infection and preparation method thereof
CN107582637B (en) One kind two is to lipid-lowering capsule
CN101757097A (en) Preparation of walnut leaf extracts and application prospect thereof in field of memory improvement and antitumor
CN101095440A (en) Slimming function of kutin tea and method for manufacturing kutin tea micro-pill

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150520